Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | IDO1 | P14902 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | MLKL | Q8NB16 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1349930 | 0.81 | ALDH1A1 (0.61) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL7533794 | 0.81 | ALDH1A1 (0.66) | ALDH1A1KDM4EHPGDIDO1POLB | |
| Hydrochloric Acid SCHEMBL11056062 | 0.79 | ALDH1A1 (0.63) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL30601597 | 0.79 | MLKL (0.77) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL3397595 | 0.79 | ALPL (0.58) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL11807688 | 0.79 | ALDH1A1 (0.58) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL899731 | 0.79 | MLKL (0.77) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL16756243 | 0.79 | ALPL (0.58) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL16756501 | 0.79 | ALPL (0.58) | ALDH1A1KDM4EHPGDIDO1POLB | |
| SCHEMBL11802373 | 0.79 | ALDH1A1 (0.58) | ALDH1A1KDM4EHPGDIDO1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107871899-A | A kind of method for preparing high-durability battery | 青岛东浩软件科技有限公司 | 2018-04-03 | — | — | CN | claimed |
| CN-107154519-A | A kind of battery liquid additive and preparation method thereof | 明光市裕阳农业有限公司 | 2017-09-12 | — | — | CN | claimed |
| US-3970535-A | Photopolymerization process utilizing a 2-methyl-substituted benzimidazole as a photosensitizer | SCM CORPORATION (US) | 1976-07-20 | — | — | US | claimed |
| CN-113424016-B | Method for obtaining information on an organic solderability preservative on a printed circuit board | 德国艾托特克公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-3924689-B1 | METHOD FOR OBTAINING INFORMATION ABOUT A LAYER OF AN ORGANIC SOLDERABILITY PRESERVATIVE ON A PRINTED CIRCUIT BOARD | ATOTECH DEUTSCHLAND GMBH & CO KG (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-20220132673-A1 | METHOD FOR OBTAINING INFORMATION ABOUT A LAYER OF AN ORGANIC SOLDERABILITY PRESERVATIVE ON A PRINTED CIRCUIT BOARD | ATOTECH DEUTSCHLAND GMBH (DE) | 2022-04-28 | — | — | US | disclosed |
| EP-3924689-A1 | METHOD FOR OBTAINING INFORMATION ABOUT A LAYER OF AN ORGANIC SOLDERABILITY PRESERVATIVE ON A PRINTED CIRCUIT BOARD | ATOTECH Deutschland GmbH (DE) | 2021-12-22 | — | — | EP | disclosed |
| WO-2020165386-A1 | METHOD FOR OBTAINING INFORMATION ABOUT A LAYER OF AN ORGANIC SOLDERABILITY PRESERVATIVE ON A PRINTED CIRCUIT BOARD | ATOTECH DEUTSCHLAND GMBH (DE) | 2020-08-20 | — | — | WO | disclosed |
| US-9034872-B2 | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | ATIR HOLDING S.A. (LU) | 2015-05-19 | — | — | US | disclosed |
| US-20140107128-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S.A. | 2014-04-17 | — | — | US | disclosed |
| EP-2233472-B1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S A (LU) | 2014-01-15 | — | — | EP | disclosed |
| US-8614319-B2 | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | ATIR HOLDING S.A. (LU) | 2013-12-24 | — | — | US | disclosed |
| US-20130072479-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S.A. (LU) | 2013-03-21 | — | — | US | disclosed |
| US-8349850-B2 | Heterocyclic compounds and uses thereof in the treatment of sexual disorders | ATIR HOLDING S.A. (LU) | 2013-01-08 | — | — | US | disclosed |
| EP-2233472-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | Atir Holding S.A. (LU) | 2010-09-29 | — | — | EP | disclosed |
| US-20100029671-A1 | Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders | ATIR HOLDING S.A. (LU) | 2010-02-04 | — | — | US | disclosed |
| EP-2010505-A2 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | Atir Holding S.A. (LU) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007110868-A2 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | ATIR HOLDING S.A. (LU) | 2007-10-04 | — | — | WO | disclosed |
| EP-0797690-A1 | PRINTED CIRCUIT BOARD MANUFACTURE | Alpha Fry Limited (GB) | 1997-10-01 | — | — | EP | disclosed |
| WO-1996017975-A1 | PRINTED CIRCUIT BOARD MANUFACTURE | ALPHA FRY LIMITED (GB) | 1996-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029671-A1 | Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders | PDE5A, PDE3B, PDE3A | ALDH1A1 656/4885KDM4E 1507/4885HPGD 74/4885 |
| US-20140107128-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | PDE5A, PDE3B, PDE3A | ALDH1A1 976/4885KDM4E 509/4885HPGD 122/4885 |
| US-20130072479-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF IN THE TREATMENT OF SEXUAL DISORDERS | PDE5A, PDE3B, PDE3A | ALDH1A1 656/4885KDM4E 1507/4885HPGD 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.